Global Pharmaceutical Environmental Monitoring Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
In pharmaceutical development and production, environmental monitoring (EM) is a process that determines the quality of a controlled environment via microbial data collection. Environmental monitoring evaluates the quality of air, surfaces, and personnel through testing and sample analysis. Environmental monitoring plays a critical role in developing sterile and non-sterile drug products.
Market Overview:The latest research study on the global Pharmaceutical Environmental Monitoring market finds that the global Pharmaceutical Environmental Monitoring market reached a value of USD 1190.73 million in 2022. It’s expected that the market will achieve USD 1716.16 million by 2028, exhibiting a CAGR of 6.28% during the forecast period.
An increase in the variety of drugs
Patients with a variety of life-threatening and debilitating diseases hope for a new drug that will improve or even save their lives. In recent years, pharmaceutical research companies are researching and developing new drugs to address unmet needs and continue research and development after approval by the U.S. Food and Drug Administration (FDA). From 2011 to 2019, CDER approved an average of about 40 new drugs per year. In 2020, CDER approved 53 new drugs. The emergence of new pharmaceutical products will increase the development of the downstream market of the Pharmaceutical Environmental Monitoring industry and provide a driving force for the development of the Pharmaceutical Environmental Monitoring industry.
Growth of Pharmaceutical Market Size
With the development of the world economy, the growth of the total population, the improvement of the aging society, and the continuous enhancement of people's health awareness, the global pharmaceutical market continues to expand rapidly. According to data released by Statista, the global pharmaceutical market has experienced significant growth in recent years. For 2022, the total global pharmaceutical market was estimated at 1.48 trillion U.S. dollars. The growth of the pharmaceutical market has expanded the downstream market of the Pharmaceutical Environmental Monitoring industry, driving Development of Pharmaceutical Environmental Monitoring Industry.
Region Overview:In 2022, the share of the Pharmaceutical Environmental Monitoring market in North America stood at 44.21%.
Company Overview:Merck KGaA is one of the major players operating in the Pharmaceutical Environmental Monitoring market, holding a share of 16.62% in 2023.
Segmentation Overview:By type, Media segment accounted for the largest share of market in 2022.
Application Overview:By application, the Traditional Pharmaceutical Industry segment occupied the biggest share from 2018 to 2022.
Key Companies in the global Pharmaceutical Environmental Monitoring market covered in Chapter 3:IVTracer
TSI Incorporated
Thermo Fisher Scientific
Merck KGaA
Cherwell Laboratories
Lonza
Wickham Micro
SGS
Vaisala
Eurofins Scientific
Element Materials Technology
Particle Measuring Systems
MBV AG
bioMérieux
VAI
In Chapter 4 and Chapter 14.2, on the basis of types, the Pharmaceutical Environmental Monitoring market from 2018 to 2029 is primarily split into:Monitoring Equipment
Media
Software
Microbiology Services
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Pharmaceutical Environmental Monitoring market from 2018 to 2029 covers:Traditional Pharmaceutical Industry
Biopharmaceutical Industry Industry
Academic & Research Institutes
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)